Beam Therapeutics Inc Share Price Today: Live Updates & Key Insights
Beam Therapeutics Inc share price today is $25.25, up -3.13%. The stock opened at $25.86 against the previous close of $25.91, with an intraday high of $25.86 and low of $24.86.
Beam Therapeutics Inc Share Price Chart
Beam Therapeutics Inc
Beam Therapeutics Inc Share Price Performance
Beam Therapeutics Inc Institutional Holdings
Beam Therapeutics Inc Market Status
Beam Therapeutics Inc Fundamentals
Market Cap 2665.60 M
PB Ratio 2.351
PE Ratio 0.0
Enterprise Value 1704.77 M
Total Assets 1481.18 M
Volume 1810181
Beam Therapeutics Inc Company Financials
About Beam Therapeutics Inc & investment objective
Company Information Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparticle (LNP) for the treatment of severe alpha-1 antitrypsin deficiency; BEAM-304, a liver-targeting LNP for the treatment of phenylketonuria; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease type 1a. The company also develops the ESCAPE platform, which combines antibody-based conditioning with multiplex gene edited HSCs. In addition, it develops BEAM-103, an anti-CD117 monoclonal antibody that enables ESCAPE. The company has research collaboration agreement with Pfizer Inc., focusing on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Verve Therapeutics, Inc., for cardiovascular disease treatments; and Orbital Therapeutics to design RNA for the prevention, treatment, or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 522
Industry Biotechnology
CEO Mr. John M. Evans M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Beam Therapeutics Inc FAQs
What is the share price of Beam Therapeutics Inc today?
The current share price of Beam Therapeutics Inc is $25.25.
Can I buy Beam Therapeutics Inc shares in India?
Yes, Indian investors can buy Beam Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Beam Therapeutics Inc shares in India?
You can easily invest in Beam Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Beam Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Beam Therapeutics Inc.
Can I buy fractional shares of Beam Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Beam Therapeutics Inc?
Beam Therapeutics Inc has a market cap of $2665.60 M.
In which sector does Beam Therapeutics Inc belong?
Beam Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Beam Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Beam Therapeutics Inc?
The PE ratio of Beam Therapeutics Inc is N/A and the PB ratio is 2.35.